Press Releases

GlobeNewswire, Inc.

CARSON CITY, Nev., May 18, 2026 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for neurological and neurodegenerative diseases, today announced that the...

GlobeNewswire, Inc.

CAMBRIDGE, Mass., May 18, 2026 (GLOBE NEWSWIRE) -- Novastra Therapeutics, a clinical-stage biotech company developing a novel category of cancer immune therapy, today announced the appointment of Jarett Poll as fractional Chief Financial Officer....

EIN Presswire

Attorney General's Phone Free Schools Support Grant creates a direct funding path for districts ready to implement phone-free classrooms BOSTON, MA, UNITED STATES, May 13, 2026 /⁨EINPresswire.com⁩/ -- The Massachusetts Office of Attorney General...

City of Boston

This week, the Council approved a series of grants that will bring significant investments into programs supporting arts and culture, seniors, youth services, public safety, workforce development, climate resilience, and economic opportunity...

EIN Presswire

Company to share how probabilistic planning solutions help it manage uncertainty and keep demand and supply balanced (Gartner Supply Chain Symposium Barcelona) BOSTON, MA, UNITED STATES, May 18, 2026 /⁨EINPresswire.com⁩/ -- Today’s supply chains...

GlobeNewswire, Inc.

BOSTON, May 14, 2026 (GLOBE NEWSWIRE) -- Zapata Quantum (OTC: ZPTA) (“Zapata”, “Zapata Quantum” or the “Company”), a pioneer in quantum computing application and algorithm development, today announced that Sumit Kapur, CEO, Dr. Jonathan Olson,...

GlobeNewswire, Inc.

Enrollment completed in ML-007C-MA’s Phase 2 ZEPHYR trial in schizophrenia, with topline results expected by mid-August 2026 Last patient visit completed for ML-004’s Phase 2 IRIS trial in autism spectrum disorder, with topline results expected by...

GlobeNewswire, Inc.

Rolling submission of Biologics License Agreement (BLA) to U.S. Food and Drug Administration (FDA) seeking ST-920 approval is in progress.

GlobeNewswire, Inc.

WATERTOWN, Mass., May 18, 2026 (GLOBE NEWSWIRE) -- EyePoint, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious retinal diseases, today announced that the...

City of Boston

National recognition highlights Boston’s leadership in preserving affordable housing and preventing displacement.

GlobeNewswire, Inc.

MIAMI, May 14, 2026 (GLOBE NEWSWIRE) -- A bold new global event in media, entertainment and sports is set to debut with the launch of Jupiter Festival, a three-day experience bringing together the world’s most influential leaders, creators and...

GlobeNewswire, Inc.

NORWOOD, Mass., May 14, 2026 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP), a clinical-stage company focused on developing promising new therapies in oncology and obesity, today announced the appointment of Brent...

EIN Presswire

XytriX™ Becomes First CTE Biotherapeutic to Reach FDA Under the Blast Overpressure Safety Act FRISCO, TX, UNITED STATES, May 18, 2026 /⁨EINPresswire.com⁩/ -- TriCelX, Inc. (“TriCelX”), a translational leader in evidence-based biotherapeutics, has...

EIN Presswire

With only days remaining, this is the final call for building owners, developers, policymakers, and sustainability professionals to secure their registration.

GlobeNewswire, Inc.

First clinical data from PRMT5/RAS(ON) combination trial to be presented in 2026 Cash position of $380 million as of March 31, 2026, with runway into 2028 beyond anticipated key data inflection points BOSTON, May 13, 2026 (GLOBE NEWSWIRE) -- Tango...

GlobeNewswire, Inc.

New Drug Application (NDA) for tebipenem HBr for complicated urinary tract infections (cUTI), including pyelonephritis, is under review at the FDA, with PDUFA date of June 18, 2026 Spero maintains its cash runway guidance into 2028 CAMBRIDGE,...

GlobeNewswire, Inc.

BOSTON, May 13, 2026 (GLOBE NEWSWIRE) -- The National Healthcareer Association (NHA), the largest allied health certification agency in the United States and an Ascend Learning brand, today released its 2026 Industry Outlook, based on a national...

GlobeNewswire, Inc.

BURLINGTON, Mass., May 13, 2026 (GLOBE NEWSWIRE) -- Cerence Inc. (NASDAQ: CRNC) (“Cerence AI”), a global leader pioneering conversational AI-powered user experiences, today announced that the Company will participate in the TD Cowen 54th Annual...

GlobeNewswire, Inc.

SAN DIEGO, May 13, 2026 (GLOBE NEWSWIRE) -- Antonio F. Santidrian, PhD, Chief Scientific Officer and Head of Technical Operations for Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or “the Company”), a biotechnology company...

GlobeNewswire, Inc.

- Appointed Jim Mercadante as Chief Commercial Officer and Dr. Todd Rasmussen as Chief Surgical Officer - - First quarter sales of Symvess® were $0.5 million in 2026 compared to $0.1 million in 2025 - - Purchase commitment received for a minimum...